
|Videos|June 12, 2020
Ocrelizumab Compared to Glatiramer Acetate and Dimethyl Fumarate for MS
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Autopsy Study Demonstrates Tofersen Distribution and SOD1 Reduction in SOD1-ALS
2
Advancing Multiple Sclerosis Treatment Through Research-Integrated Clinical Care
3
Clinical Utility and Practical Challenges of OCT in the 2024 McDonald Criteria for MS: Rachel Kenney, PhD
4
Key Lessons Learned: Optimizing Anti-CD20 Therapy for Long-Term MS Care
5


























